SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-21-014898
Filing Date
2021-03-23
Accepted
2021-03-23 17:12:20
Documents
77
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K scph-10k_20201231.htm 10-K 2365780
2 EX-4.2 scph-ex42_6.htm EX-4.2 37827
3 EX-21.1 scph-ex211_9.htm EX-21.1 4078
4 EX-23.1 scph-ex231_8.htm EX-23.1 3627
5 EX-31.1 scph-ex311_7.htm EX-31.1 20267
6 EX-32.1 scph-ex321_11.htm EX-32.1 9863
  Complete submission text file 0001564590-21-014898.txt   8239404

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT scph-20201231.xml EX-101.INS 1714361
8 XBRL TAXONOMY EXTENSION SCHEMA scph-20201231.xsd EX-101.SCH 58365
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE scph-20201231_cal.xml EX-101.CAL 64998
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE scph-20201231_def.xml EX-101.DEF 177634
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE scph-20201231_lab.xml EX-101.LAB 487997
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE scph-20201231_pre.xml EX-101.PRE 368043
Mailing Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803
Business Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Filer) CIK: 0001604950 (see all company filings)

IRS No.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38293 | Film No.: 21765587
SIC: 2834 Pharmaceutical Preparations